Assessment of immune mediator expression levels in biological fluids and cells

A critical appraisal

R. Patarca, D. Sandler, J. Walling, B. C. Lunn, M. A. Fletcher

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The realization that dysregulation of the soluble immune mediator network can contribute to the progression of a wide variety of clinical disorders, including neoplasias, has opened up the possibility of designing new forms of therapy and has established the need for accurate methods of detection of immune mediator expression levels in biological fluids and cells.The purpose of this review is to provide a summary of current knowledge and experience in the area of immune mediator expression level assessment from the clinical, basic science, epidemiological, technical, and therapeutic perspectives.

Original languageEnglish
Pages (from-to)117-149
Number of pages33
JournalCritical Reviews in Oncogenesis
Volume6
Issue number2
StatePublished - Dec 1 1995
Externally publishedYes

Fingerprint

Therapeutics
Neoplasms

Keywords

  • bioassay
  • cytokines
  • ELISA
  • immunoassay
  • interleukin
  • polymerase chain reaction
  • sensitivity
  • soluble receptors
  • specifici ty

ASJC Scopus subject areas

  • Cancer Research

Cite this

Patarca, R., Sandler, D., Walling, J., Lunn, B. C., & Fletcher, M. A. (1995). Assessment of immune mediator expression levels in biological fluids and cells: A critical appraisal. Critical Reviews in Oncogenesis, 6(2), 117-149.

Assessment of immune mediator expression levels in biological fluids and cells : A critical appraisal. / Patarca, R.; Sandler, D.; Walling, J.; Lunn, B. C.; Fletcher, M. A.

In: Critical Reviews in Oncogenesis, Vol. 6, No. 2, 01.12.1995, p. 117-149.

Research output: Contribution to journalArticle

Patarca, R, Sandler, D, Walling, J, Lunn, BC & Fletcher, MA 1995, 'Assessment of immune mediator expression levels in biological fluids and cells: A critical appraisal', Critical Reviews in Oncogenesis, vol. 6, no. 2, pp. 117-149.
Patarca, R. ; Sandler, D. ; Walling, J. ; Lunn, B. C. ; Fletcher, M. A. / Assessment of immune mediator expression levels in biological fluids and cells : A critical appraisal. In: Critical Reviews in Oncogenesis. 1995 ; Vol. 6, No. 2. pp. 117-149.
@article{342a9ae1a6ed4871a1f8930d3eb08cea,
title = "Assessment of immune mediator expression levels in biological fluids and cells: A critical appraisal",
abstract = "The realization that dysregulation of the soluble immune mediator network can contribute to the progression of a wide variety of clinical disorders, including neoplasias, has opened up the possibility of designing new forms of therapy and has established the need for accurate methods of detection of immune mediator expression levels in biological fluids and cells.The purpose of this review is to provide a summary of current knowledge and experience in the area of immune mediator expression level assessment from the clinical, basic science, epidemiological, technical, and therapeutic perspectives.",
keywords = "bioassay, cytokines, ELISA, immunoassay, interleukin, polymerase chain reaction, sensitivity, soluble receptors, specifici ty",
author = "R. Patarca and D. Sandler and J. Walling and Lunn, {B. C.} and Fletcher, {M. A.}",
year = "1995",
month = "12",
day = "1",
language = "English",
volume = "6",
pages = "117--149",
journal = "Critical Reviews in Oncogenesis",
issn = "0893-9675",
publisher = "Begell House Inc.",
number = "2",

}

TY - JOUR

T1 - Assessment of immune mediator expression levels in biological fluids and cells

T2 - A critical appraisal

AU - Patarca, R.

AU - Sandler, D.

AU - Walling, J.

AU - Lunn, B. C.

AU - Fletcher, M. A.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - The realization that dysregulation of the soluble immune mediator network can contribute to the progression of a wide variety of clinical disorders, including neoplasias, has opened up the possibility of designing new forms of therapy and has established the need for accurate methods of detection of immune mediator expression levels in biological fluids and cells.The purpose of this review is to provide a summary of current knowledge and experience in the area of immune mediator expression level assessment from the clinical, basic science, epidemiological, technical, and therapeutic perspectives.

AB - The realization that dysregulation of the soluble immune mediator network can contribute to the progression of a wide variety of clinical disorders, including neoplasias, has opened up the possibility of designing new forms of therapy and has established the need for accurate methods of detection of immune mediator expression levels in biological fluids and cells.The purpose of this review is to provide a summary of current knowledge and experience in the area of immune mediator expression level assessment from the clinical, basic science, epidemiological, technical, and therapeutic perspectives.

KW - bioassay

KW - cytokines

KW - ELISA

KW - immunoassay

KW - interleukin

KW - polymerase chain reaction

KW - sensitivity

KW - soluble receptors

KW - specifici ty

UR - http://www.scopus.com/inward/record.url?scp=0029548495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029548495&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 117

EP - 149

JO - Critical Reviews in Oncogenesis

JF - Critical Reviews in Oncogenesis

SN - 0893-9675

IS - 2

ER -